STAT January 25, 2022
Casey Ross and Katie Palmer

IBM sells Watson Health data on 270 million Americans

The Watson Health era is over at IBM. The company sold the core data and analytics assets of its struggling health division to Francisco Partners, a San Francisco-based private equity firm with an active portfolio of health technology investments. The deal ends a dark chapter for IBM, which failed to live up to its promises to use AI to revolutionize drug discovery, cancer care, and hospital operations. It also instantly makes Francisco Partners a significant player in a growing national market for buying and selling sensitive patient data. The firm will soon own the national MarketScan insurance claims database, which includes medical and drug data on more than 270 million Americans, as well as smaller datasets containing...

Today's Sponsors

H1
ZeOmega
Holon

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

Premier

 
Topics: Digital Health, Health IT, Patient / Consumer, Provider, Technology, Telehealth
ATA 2022: A Shining Moment for the Meaningful Use of Telehealth Technology
Telemedicine Diagnoses for Neurological Patients Effective, but Room to Improve
How will telehealth impact health equity?
Virtual Care Intimacy
Is Telemedicine Closing the 'Race Gap' in Primary Care?